Inventor · disambiguated record
Adam Shultz Adler
Also filed as: ADLER ADAM · ADLER ADAM SHULTZ
20 granted patents·10 pending applications·91 citations·filing 1997–2025
93Inventor score
Top patents by PatentIndex Score
30 records- 0196US9422547B1Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2015·Granted Aug 23, 2016·11 cites·16 claims
- 0295US9738699B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2016·Granted Aug 22, 2017·9 cites·12 claims
- 0392US10329557B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2018·Granted Jun 25, 2019·9 cites·16 claims
- 0492US9926555B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2017·Granted Mar 27, 2018·5 cites·4 claims
- 0589US10689641B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2019·Granted Jun 23, 2020·2 cites·3 claims
- 0683US12241178B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2022·Granted Mar 4, 2025·0 cites·12 claims
- 0783US11702765B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2020·Granted Jul 18, 2023·1 cites·10 claims
- 0883US9926554B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2017·Granted Mar 27, 2018·1 cites·5 claims
- 0980US12195880B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2022·Granted Jan 14, 2025·0 cites·16 claims
- 1079US10214740B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2016·Granted Feb 26, 2019·1 cites·5 claims
- 1179US2025179689A1Recombinant Fusion Proteins and Libraries from Immune Cell RepertoiresGIGAGEN INC·Filed 2025·Application pending·0 cites
- 1278US6187306B1Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using sameUNIV JOHNS HOPKINS·Filed 1997·Granted Feb 13, 2001·51 cites·17 claims
- 1376US11427933B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2021·Granted Aug 30, 2022·0 cites·13 claims
- 1474US11441240B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2019·Granted Sep 13, 2022·0 cites·5 claims
- 1573US11111490B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2019·Granted Sep 7, 2021·0 cites·13 claims
- 1672US12421311B2Anti-CTLA-4 binding proteins and methods of use thereofGIGAGEN INC·Filed 2019·Granted Sep 23, 2025·1 cites·14 claims
- 1771US12404607B2Recombinant polyclonal proteins targeting COVID-19 and methods of use thereofGIGAGEN INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 1865US2023265171A1Recombinant polyclonal proteins targeting zika and methods of use thereofGIGAGEN INC·Filed 2023·Application pending·0 cites
- 1964US12497711B2Engineered cells expressing anti-viral T cell receptors and methods of use thereofGIGAMUNE INC·Filed 2022·Granted Dec 16, 2025·0 cites·12 claims
- 2064US11685779B2Recombinant polyclonal proteins targeting COVID-19 and methods of use thereofGIGAGEN INC·Filed 2021·Granted Jun 27, 2023·0 cites·10 claims
- 2159US11718660B2Recombinant polyclonal proteins targeting Zika and methods of use thereofGIGAGEN INC·Filed 2021·Granted Aug 8, 2023·0 cites·6 claims
- 2256US2025333794A1Hypogammaglobulinemia patient selection for immunoglobulin replacement therapyGIGAGEN INC·Filed 2025·Application pending·0 cites
- 2355US2025289888A1Anti-CTLA-4 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2022·Application pending·0 cites
- 2455US2024132593A1Anti-vista antibodies and uses thereofKINETA INC·Filed 2022·Application pending·0 cites
- 2551US11421220B2Engineered cells expressing anti-viral T cell receptors and methods of use thereofGIGAMUNE INC·Filed 2021·Granted Aug 23, 2022·0 cites·14 claims
- 2649US2023265192A1Anti-ctla-4 binding proteins and methods of use thereofGIGAGEN INC·Filed 2021·Application pending·0 cites
- 2745US2022213167A1Engineered cells expressing anti-tumor t cell receptors and methods of use thereofGIGAMUNE INC·Filed 2020·Application pending·0 cites
- 2843US2022064302A1Anti-PD-1 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2019·Application pending·0 cites
- 2943US2022056137A1Anti-PD-L1 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2019·Application pending·0 cites
- 3041US2010279302A1Methods of predicting pairability and secondary structures of rna moleculesYEDA RES & DEV·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Shultz Adler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →